Skip to main content

Orchard Therapeutics plc

ORTXDelisted
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001748907

Orchard Therapeutics plc was delisted in 2024; its insiders filed their last Form 4 on Jan 24, 2024; 47 institutions reported holding it in 13F filings for Q4 2023, worth $122.5M in total; no superinvestor held it.

13F holders, Q4 2023

Institutional positions in Orchard Therapeutics plc as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

ORTX is no longer listed, so this page shows Q4 2023. 13F filings for later quarters list far fewer holders.

Institutional holders
47
+16 vs. Q3 2023
Shares held
8.88M
+4.62M (+108.7%) vs. Q3 2023
Total value
$122.5M
+$89.6M (+272.4%) vs. Q3 2023
New holders
27
5 more added
Sold out
11
4 more reduced

1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ORTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2023: 47 institutions
Q1 2021: 83 institutionsQ2 2021: 85 institutionsQ3 2021: 79 institutionsQ4 2021: 72 institutionsQ1 2022: 61 institutionsQ2 2022: 50 institutionsQ3 2022: 47 institutionsQ4 2022: 47 institutionsQ1 2023: 35 institutionsQ2 2023: 33 institutionsQ3 2023: 32 institutionsQ4 2023: 47 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ4 2023: $122.5M
Q1 2021: $546.4MQ2 2021: $350.8MQ3 2021: $167.4MQ4 2021: $84.7MQ1 2022: $38.9MQ2 2022: $30.2MQ3 2022: $24.7MQ4 2022: $16.3MQ1 2023: $31.2MQ2 2023: $26.2MQ3 2023: $46.9MQ4 2023: $122.5MQ1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding ORTX and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 202347$122.5M
Q3 202332$46.9M
Q2 202333$26.2M
Q1 202335$31.2M
Q4 202247$16.3M
Q3 202247$24.7M
Q2 202250$30.2M
Q1 202261$38.9M
Q4 202172$84.7M
Q3 202179$167.4M
Q2 202185$350.8M
Q1 202183$546.4M

Institutions, Q4 2023

Shares, value and share of portfolio for each institution holding Orchard Therapeutics plc; share changes are against Q3 2023.

Institutions holding ORTX in Q4 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Deep Track Capital, LP2,041,670$33.6M1.18%00.0%Unchanged
Beryl Capital Management LLC1,561,499$25.7M14.11%+1,561,499New
Federated Hermes, Inc.869,327$14.3M0.04%00.0%Unchanged
LMR Partners LLP332,223$5.47M0.14%+332,223New
Tudor Investment Corp Et Al300,000$4.93M0.07%+300,000New
Millennium Management LLC238,852$3.93M0.00%+238,852New
Gabelli Funds LLC224,250$3.69M0.03%+224,250New
Renaissance Technologies LLC196,918$3.24M0.01%+82,100+71.5%Added
Gabelli & Co Investment Advisers, Inc.192,650$3.17M0.59%+192,650New
Qube Research & Technologies Ltd172,579$2.84M0.01%+172,576+5,752,533.3%Added
Blue Owl Capital Holdings LP1,599,660$2.63M0.63%+1,599,660New
Yakira Capital Management, Inc.144,826$2.38M0.78%+144,826New
Skandinaviska Enskilda Banken AB (publ)140,500$2.31M0.01%+140,500New
Goldman Sachs Group Inc137,520$2.26M0.00%+137,520New
Prelude Capital Management, LLC116,316$1.91M0.17%+116,316New
Water Island Capital LLC91,000$1.50M0.15%+91,000New
CSS LLC63,921$1.05M0.08%+63,921New
ADAR1 Capital Management, LLC63,622$1.05M0.47%+63,622New
JPMorgan Chase & Co54,368$894.4K0.00%+32,958+153.9%Added
BCK Capital Management LP43,642$717.9K0.70%+43,642New
Jane Street Group, LLC42,291$695.7K0.00%+42,291New
FMR LLC41,228$678.2K0.00%00.0%Unchanged
Carmignac Gestion39,468$649.2K0.01%+39,468New
Susquehanna International Group, LLP34,028$559.8K0.00%+20,583+153.1%Added
PenderFund Capital Management Ltd.23,580$514.0K0.17%+23,580New
HRT Financial LP24,737$406.0K0.00%+24,737New
Gamco Investors, Inc. Et Al15,188$249.8K0.00%+15,188New
GTS Securities LLC15,000$246.8K0.01%+15,000New
FNY Investment Advisers, LLC15,000$246.0K0.28%+15,000New
Vident Advisory, LLC11,270$185.4K0.00%+11,270New
Woodline Partners LP10,000$164.5K0.00%00.0%Unchanged
Harvest Management LLC10,000$164.5K0.19%+10,000New
Morgan Stanley4,372$71.9K0.00%−7,616−63.5%Reduced
EntryPoint Capital, LLC2,020$33.2K0.03%+2,020New
Rhumbline Advisers1,318$21.7K0.00%+1,176+828.2%Added
Group One Trading, L.P.1,197$19.7K0.00%+1,197New
Wells Fargo & Company1,150$18.9K0.00%−100−8.0%Reduced
Advisor Group Holdings, Inc.562$9.24K0.00%−790−58.4%Reduced
Banque Cantonale Vaudoise400$7.00K0.00%−10,000−96.2%Reduced
UBS Group AG380$6.25K0.00%00.0%Unchanged
Bank of America Corp283$4.66K0.00%00.0%Unchanged
Citigroup Inc110$1.81K0.00%00.0%Unchanged
Concord Wealth Partners100$1.65K0.00%00.0%Unchanged
CWM, LLC83$1.00K0.00%00.0%Unchanged
Beaird Harris Wealth Management, LLC12$1980.00%00.0%Unchanged
Mine & Arao Wealth Creation & Management, LLC.10$1650.00%00.0%Unchanged
Compass Wealth Management LLC9$1490.00%+9New
Deerfield Management Company, L.P. (Series C)0$00.00%−316,169−100.0%Sold out
Platinum Investment Management Ltd0$00.00%−248,462−100.0%Sold out
Mariner, LLC0$00.00%−192,250−100.0%Sold out
Acadian Asset Management LLC0$00.00%−120,658−100.0%Sold out
Citadel Advisors LLC0$00.00%−95,272−100.0%Sold out
UBS Oconnor LLC0$00.00%−71,010−100.0%Sold out
Stifel Financial Corp0$00.00%−31,418−100.0%Sold out
Cormorant Asset Management, LP0$00.00%−25,664−100.0%Sold out
Forefront Analytics, LLC0$00.00%−14,183−100.0%Sold out
Global Retirement Partners, LLC0$00.00%−1,000−100.0%Sold out
Royal Bank of Canada0$00.00%−100−100.0%Sold out
CHI Advisors LLC––––Not filed